NasdaqCM - Nasdaq Real Time Price USD
Jade Biosciences, Inc. (JBIO)
6.76
-0.18
(-2.59%)
At close: 4:00:01 PM EDT
6.76
0.00
(0.00%)
After hours: 4:00:13 PM EDT
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Tom Frohlich | CEO & Director | -- | -- | 1976 |
| Mr. Jonathan Quick | Senior Vice President of Finance | -- | -- | -- |
| Dr. Andrew James King D.V.M., Ph.D. | Chief Scientific Officer & Head of R&D | -- | -- | 1980 |
| Ms. Elizabeth Balta | General Counsel & Corporate Secretary | -- | -- | -- |
| Ms. Lori Stewart | Senior Vice President of People | -- | -- | -- |
| Dr. Hetal Kocinsky M.D. | Chief Medical Officer | -- | -- | -- |
| Dr. Jason Wright Ph.D. | Senior Vice President, Chemistry, Manufacturing & Controls | -- | -- | -- |
| Ms. Valerie Fauvelle | Senior Vice President of Regulatory & Quality | -- | -- | -- |
| Ms. Amy Sullivan | Senior Vice President of Development Operations | -- | -- | -- |
| Ms. Sandy Lewis | Senior Vice President, Biometrics & Clinical Strategy | -- | -- | -- |
Jade Biosciences, Inc.
221 Crescent Street Building 23
Suite 105
Waltham, MA 02453
United States
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 30
Description
Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. The company was incorporated in 2024 and is headquartered in Waltham, Massachusetts.
Corporate Governance
Jade Biosciences, Inc.’s ISS Governance QualityScore as of June 1, 2025 is 8. The pillar scores are Audit: 6; Board: 7; Shareholder Rights: 8; Compensation: 9.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
August 11, 2025 at 8:00 PM UTC
Jade Biosciences, Inc. Earnings Date
Recent Events
April 28, 2025 at 12:00 AM UTC
Dividend Date
Related Tickers
SYRE Spyre Therapeutics, Inc.
17.29
-2.37%
IRON Disc Medicine, Inc.
53.71
+1.90%
TYRA Tyra Biosciences, Inc.
10.43
+0.97%
ORKA Oruka Therapeutics, Inc.
12.56
-2.41%
KROS Keros Therapeutics, Inc.
13.56
-0.59%
APGE Apogee Therapeutics, Inc.
44.48
+6.26%
COGT Cogent Biosciences, Inc.
7.08
-1.94%
CLYM Climb Bio, Inc.
1.2600
-1.56%
TECX Tectonic Therapeutic, Inc.
21.89
-2.45%
DYN Dyne Therapeutics, Inc.
14.41
-0.35%